Antibiotice (Romania) Performance
| ATB Stock | 2.70 0.02 0.75% |
The firm shows a Beta (market volatility) of -0.61, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Antibiotice are expected to decrease at a much lower rate. During the bear market, Antibiotice is likely to outperform the market. At this point, Antibiotice Ia has a negative expected return of -0.12%. Please make sure to confirm Antibiotice's accumulation distribution, and the relationship between the potential upside and day median price , to decide if Antibiotice Ia performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Antibiotice Ia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental drivers remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors. ...more
Antibiotice |
Antibiotice Relative Risk vs. Return Landscape
If you would invest 300.00 in Antibiotice Ia on September 12, 2024 and sell it today you would lose (30.00) from holding Antibiotice Ia or give up 10.0% of portfolio value over 90 days. Antibiotice Ia is producing return of less than zero assuming 2.9537% volatility of returns over the 90 days investment horizon. Simply put, 26% of all stocks have less volatile historical return distribution than Antibiotice, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Antibiotice Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Antibiotice's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Antibiotice Ia, and traders can use it to determine the average amount a Antibiotice's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0394
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ATB |
Estimated Market Risk
| 2.95 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Antibiotice is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Antibiotice by adding Antibiotice to a well-diversified portfolio.
About Antibiotice Performance
By examining Antibiotice's fundamental ratios, stakeholders can obtain critical insights into Antibiotice's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Antibiotice is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Antibiotice Ia performance evaluation
Checking the ongoing alerts about Antibiotice for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Antibiotice Ia help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Antibiotice Ia generated a negative expected return over the last 90 days |
- Analyzing Antibiotice's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Antibiotice's stock is overvalued or undervalued compared to its peers.
- Examining Antibiotice's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Antibiotice's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Antibiotice's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Antibiotice's stock. These opinions can provide insight into Antibiotice's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Antibiotice Stock
Antibiotice financial ratios help investors to determine whether Antibiotice Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Antibiotice with respect to the benefits of owning Antibiotice security.